Registres
Chaque registre avec son nombre de médicaments et quelques-uns d’entre eux.
États-Unis
FDA · 18 médicaments
- Adderall XR 102.5MG; 2.5MG; 2.5MG; 2.5MG · capsule, extended release · Takeda Pharms USA
- Adderall XR 153.75MG; 3.75MG; 3.75MG; 3.75MG · capsule, extended release · Takeda Pharms USA
- Adderall XR 205MG; 5MG; 5MG; 5MG · capsule, extended release · Takeda Pharms USA
- Adderall XR 256.25MG; 6.25MG; 6.25MG; 6.25MG · capsule, extended release · Takeda Pharms USA
Tous les médicaments contenant Dextroamphetamine saccharate
Tous les registres, page par page. Dosages et conditionnements figurent sur la page de chaque médicament.
28 résultats
| Médicament | Registre | Dosage | Forme | Statut | Titulaire |
|---|---|---|---|---|---|
| Dextroamphetamine Saccharate; Amphetamine Aspartate Monohydrate; Dextroamphetamine Sulfate; Amphetamine SulfateAssociation | États-Unis | 10MG, 15MG, 20MG … | capsule, extended release | Approbation provisoire | Corepharma |
| Dextroamp Saccharate, Amp Aspartate, Dextroamp Sulfate and Amp SulfateAssociation | États-Unis | 1.25MG; 1.25MG; 1.25MG; 1.25MG, 1.875MG; 1.875MG; 1.875MG; 1.875MG, 2.5MG; 2.5MG; 2.5MG; 2.5MG … | tablet | Commercialisé | Actavis Elizabeth |
| Dextroamp Saccharate, Amp Aspartate, Dextroamp Sulfate and Amp SulfateAssociation | États-Unis | 1.25MG; 1.25MG; 1.25MG; 1.25MG, 12.5MG; 12.5MG; 12.5MG; 12.5MG, 2.5MG; 2.5MG; 2.5MG; 2.5MG … | capsule, extended release | Commercialisé | Ani Pharms |
| Dextroamp Saccharate,Amp Aspartate,Dextroamp Sulfate and Amp SulfateAssociation | États-Unis | 1.25MG; 1.25MG; 1.25MG; 1.25MG, 2.5MG; 2.5MG; 2.5MG; 2.5MG, 3.75MG; 3.75MG; 3.75MG; 3.75MG … | capsule, extended release | Non commercialisé | Barr Labs INC |
| Adderall XR 10Association | États-Unis | 2.5MG; 2.5MG; 2.5MG; 2.5MG | capsule, extended release | Commercialisé | Takeda Pharms USA |
| Adderall XR 15Association | États-Unis | 3.75MG; 3.75MG; 3.75MG; 3.75MG | capsule, extended release | Commercialisé | Takeda Pharms USA |
| Adderall XR 20Association | États-Unis | 5MG; 5MG; 5MG; 5MG | capsule, extended release | Commercialisé | Takeda Pharms USA |
| Adderall XR 25Association | États-Unis | 6.25MG; 6.25MG; 6.25MG; 6.25MG | capsule, extended release | Commercialisé | Takeda Pharms USA |
| Adderall XR 30Association | États-Unis | 7.5MG; 7.5MG; 7.5MG; 7.5MG | capsule, extended release | Commercialisé | Takeda Pharms USA |
| Adderall XR 5Association | États-Unis | 1.25MG; 1.25MG; 1.25MG; 1.25MG | capsule, extended release | Commercialisé | Takeda Pharms USA |
| MydayisAssociation | États-Unis | 12.5MG; 12.5MG; 12.5MG; 12.5MG, 3.125MG; 3.125MG; 3.125MG; 3.125MG, 6.25MG; 6.25MG; 6.25MG; 6.25MG … | capsule, extended release | Commercialisé | Takeda Pharms USA |
| Dextroamphetamine Sulfate | États-Unis | 5MG/5ML | solution | Commercialisé | Tris Pharma INC |
| Dextroamphetamine Sulfate | États-Unis | 10MG, 15MG, 5MG | capsule, extended release | Commercialisé | Specgx LLC |
| Dextroamphetamine Sulfate | États-Unis | 10MG, 15MG, 15MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** … | tablet | Commercialisé | Aurolife Pharma LLC |
| Adderall 10Association | États-Unis | 2.5MG; 2.5MG; 2.5MG; 2.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | tablet | Non commercialisé | Teva Womens |
| Adderall 12.5Association | États-Unis | 3.125MG; 3.125MG; 3.125MG; 3.125MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | tablet | Non commercialisé | Teva Womens |
| Adderall 15Association | États-Unis | 3.75MG; 3.75MG; 3.75MG; 3.75MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | tablet | Non commercialisé | Teva Womens |
| Adderall 20Association | États-Unis | 5MG; 5MG; 5MG; 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | tablet | Non commercialisé | Teva Womens |
| Adderall 30Association | États-Unis | 7.5MG; 7.5MG; 7.5MG; 7.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | tablet | Non commercialisé | Teva Womens |
| Adderall 5Association | États-Unis | 1.25MG; 1.25MG; 1.25MG; 1.25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | tablet | Non commercialisé | Teva Womens |
| Adderall 7.5Association | États-Unis | 1.875MG; 1.875MG; 1.875MG; 1.875MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | tablet | Non commercialisé | Teva Womens |
| Dextroamphetamine | Canada | 5 MG | Tablet | Commercialisé | Aa Pharma INC |
| PMS-Dextroamphetamine | Canada | 5 MG | Tablet | Commercialisé | Pharmascience INC |
| Teva-Dextroamphetamine SR | Canada | 15 MG | Capsule (Sustained-Release) | Commercialisé | Teva Canada Limited |
| Teva-Dextroamphetamine SR | Canada | 10 MG | Capsule (Sustained-Release) | Commercialisé | Teva Canada Limited |
En bref
- Registres
- 1
- Médicaments
- 18
- Laboratoires
- 6